Hurler's Syndrome
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants (NCT00418821) | Genzyme, a Sanofi Company | 2010-10-22 |
| Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism (NCT00668564) | Masonic Cancer Center, University of Minnesota | 2008-03-01 |
| A Dose-optimization Study of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I (MPS I) Disease (NCT00144781) | Genzyme, a Sanofi Company | 2004-12-01 |
| A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients (NCT00144768) | Genzyme, a Sanofi Company | 2004-07-01 |
| Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients (NCT00146770) | Genzyme, a Sanofi Company | 2001-05-01 |
Track Hurler's Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.